logo
ResearchBunny Logo
Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case

Medicine and Health

Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case

Y. Wang, C. Liu, et al.

Explore the groundbreaking cost-effectiveness analysis of an AI model in diabetic retinopathy screening conducted by leading researchers including Yueye Wang and Mingguang He. This study uncovers that while AI models achieve high diagnostic accuracy, not all are cost-effective, especially dependent on sensitivity and prevalence factors. Discover the key insights that could change health screening approaches!

00:00
00:00
~3 min • Beginner • English
Abstract
Artificial intelligence (AI) models have shown great accuracy in health screening. However, for real-world implementation, high accuracy may not guarantee cost-effectiveness. Improving AI's sensitivity finds more high-risk patients but may raise medical costs while increasing specificity reduces unnecessary referrals but may weaken detection capability. To evaluate the trade-off between AI model performance and the long-running cost-effectiveness, we conducted a cost-effectiveness analysis in a nationwide diabetic retinopathy (DR) screening program in China, comprising 251,535 participants with diabetes over 30 years. We tested a validated AI model in 1100 different diagnostic performances (presented as sensitivity/specificity pairs) and modeled annual screening scenarios. The status quo was defined as the scenario with the most accurate AI performance. The incremental cost-effectiveness ratio (ICER) was calculated for other scenarios against the status quo as cost-effectiveness metrics. Compared to the status quo (sensitivity/specificity: 93.3%/87.7%), six scenarios were cost-saving and seven were cost-effective. To achieve cost-saving or cost-effective, the AI model should reach a minimum sensitivity of 88.2% and specificity of 80.4%. The most cost-effective AI model exhibited higher sensitivity (96.3%) and lower specificity (80.4%) than the status quo. In settings with higher DR prevalence and willingness-to-pay levels, the AI needed higher sensitivity for optimal cost-effectiveness. Urban regions and younger patient groups also required higher sensitivity in AI-based screening. In real-world DR screening, the most accurate AI model may not be the most cost-effective. Cost-effectiveness should be independently evaluated, which is most likely to be affected by the AI's sensitivity.
Publisher
npj Digital Medicine
Published On
Feb 21, 2024
Authors
Yueye Wang, Chi Liu, Wenyi Hu, Lixia Luo, Danli Shi, Jian Zhang, Qiuxia Yin, Lei Zhang, Xiaotong Han, Mingguang He
Tags
Artificial intelligence
diabetic retinopathy
cost-effectiveness
health screening
diagnostic performance
sensitivity
specificity
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny